Cutaneously applied erythromycin base reduces various types of inflammatory reactions in mouse ear. 1987

J P Tarayre, and M Aliaga, and M Barbara, and G Villanova, and R Ballester, and J Tisne-Versailles, and J P Couzinier

Erythromycin base was tested by brushing a solution onto the skin in various models of non-immune and immune inflammation produced in mouse ear, namely inflammations induced by croton oil and cantharidin, primary irritation by picryl chloride, and contact hypersensitivity reactions to oxazolone and picryl chloride. On the non-immune inflammations, erythromycin displayed a greater effect than indomethacin, phenylbutazone or acetylsalicylic acid, though less than that of hydrocortisone acetate. It inhibited the hypersensitivity reactions less well. These results suggest some participation of an anti-inflammatory mechanism in the clinical effectiveness of cutaneously applied erythromycin base in some forms of acne.

UI MeSH Term Description Entries
D006967 Hypersensitivity Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen. Allergy,Allergic Reaction,Allergic Reactions,Allergies,Hypersensitivities,Reaction, Allergic,Reactions, Allergic
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008297 Male Males
D010853 Picryl Chloride A hapten that generates suppressor cells capable of down-regulating the efferent phase of trinitrophenol-specific contact hypersensitivity. (Arthritis Rheum 1991 Feb;34(2):180). 2,4,6-Trinitro-1-chlorobenzene,1-Chloro-2,4,6-trinitrobenzene,Trinitrochlorobenzene,Chloride, Picryl
D002193 Cantharidin A toxic compound, isolated from the Spanish fly or blistering beetle (Lytta (Cantharis) vesicatoria) and other insects. It is a potent and specific inhibitor of protein phosphatases 1 (PP1) and 2A (PP2A). This compound can produce severe skin inflammation, and is extremely toxic if ingested orally. Cantharides,Cantharidine
D003436 Croton Oil Viscous, nauseating oil obtained from the shrub Croton tiglium (Euphorbaceae). It is a vesicant and skin irritant used as pharmacologic standard for skin inflammation and allergy and causes skin cancer. It was formerly used as an emetic and cathartic with frequent mortality. Oil, Croton
D004423 Ear The hearing and equilibrium system of the body. It consists of three parts: the EXTERNAL EAR, the MIDDLE EAR, and the INNER EAR. Sound waves are transmitted through this organ where vibration is transduced to nerve signals that pass through the ACOUSTIC NERVE to the CENTRAL NERVOUS SYSTEM. The inner ear also contains the vestibular organ that maintains equilibrium by transducing signals to the VESTIBULAR NERVE. Vestibulocochlear System,Vestibulocochlear Apparatus,Apparatus, Vestibulocochlear,Ears,System, Vestibulocochlear
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

J P Tarayre, and M Aliaga, and M Barbara, and G Villanova, and R Ballester, and J Tisne-Versailles, and J P Couzinier
April 1980, Journal of the American Academy of Dermatology,
J P Tarayre, and M Aliaga, and M Barbara, and G Villanova, and R Ballester, and J Tisne-Versailles, and J P Couzinier
April 1983, International journal of clinical pharmacology, therapy, and toxicology,
J P Tarayre, and M Aliaga, and M Barbara, and G Villanova, and R Ballester, and J Tisne-Versailles, and J P Couzinier
August 1997, Antiviral research,
J P Tarayre, and M Aliaga, and M Barbara, and G Villanova, and R Ballester, and J Tisne-Versailles, and J P Couzinier
January 1966, Archiv fur klinische und experimentelle Dermatologie,
J P Tarayre, and M Aliaga, and M Barbara, and G Villanova, and R Ballester, and J Tisne-Versailles, and J P Couzinier
March 2000, Arzneimittel-Forschung,
J P Tarayre, and M Aliaga, and M Barbara, and G Villanova, and R Ballester, and J Tisne-Versailles, and J P Couzinier
October 1955, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
J P Tarayre, and M Aliaga, and M Barbara, and G Villanova, and R Ballester, and J Tisne-Versailles, and J P Couzinier
November 1966, Zeitschrift fur Haut- und Geschlechtskrankheiten,
J P Tarayre, and M Aliaga, and M Barbara, and G Villanova, and R Ballester, and J Tisne-Versailles, and J P Couzinier
May 1957, Minerva medica,
J P Tarayre, and M Aliaga, and M Barbara, and G Villanova, and R Ballester, and J Tisne-Versailles, and J P Couzinier
May 1999, Carcinogenesis,
J P Tarayre, and M Aliaga, and M Barbara, and G Villanova, and R Ballester, and J Tisne-Versailles, and J P Couzinier
August 1984, Environmental health perspectives,
Copied contents to your clipboard!